Budget Impact Analysis of Tocilizumab, Infliximab and Etanercept Drugs for The Treatment of Rheumatoid Arthritis in Ecuador
Abstract
Authors
V Briceno F Naranjo JD Moscoso D Salazar
V Briceno F Naranjo JD Moscoso D Salazar
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now